New Jersey: common questions

There is no blanket permission for psychedelic therapy. Hospital psilocybin pilot program. Exceptions, personal-use protections or reduced enforcement do not by themselves authorize treatment services.

P.L. 2025, c.296 (S2283), P.L. 2025, c.296, signed January 20, 2026, creates a psilocybin pilot program at three New Jersey hospitals and funds it. Possession outside the program remains a crime.

Access only through the hospital pilot program once running Possession outside the program remains illegal

We don't have a licensing authority on record for listed providers here.

6 listed; 0 with a license confirmed against an official registry.

Ketamine therapy, Ketamine therapy and Spravato (esketamine), IV ketamine and Spravato (esketamine), Spravato (esketamine) treatment.

No stage-specific remote arrangement is documented in these listings. 0 unique listings have a remote-service or support record. Unknown arrangements are not evidence that remote support is unavailable. Preparation and integration are separate from administration; these records do not establish legal permission or clinical eligibility for remote treatment.

No. Laws change often, confirm with the official sources below or a licensed attorney.